Back
34
Day Range
$3.08
$3.21
52-Week Range
$2.98
$7.18
Volume
13,054,494
50D / 200D Avg
$3.92
/
$4.80
Prev Close
$3.23
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -2.2 | 0.3 |
| P/B | 1.3 | 2.9 |
| ROE % | -59.5 | 3.7 |
| Net Margin % | -863.4 | 3.8 |
| Rev Growth 5Y % | 65.3 | 10.0 |
| D/E | 0.1 | 0.2 |
Analyst Price Target
Hold
$11.00
+247.0%
Forward EPS
-$0.95
Est. Revenue
85 M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2029 |
-$0.94
-$2.00 – -$0.51
|
250 M | 4 |
| FY2028 |
-$0.45
-$0.95 – -$0.24
|
440 M | 3 |
| FY2027 |
-$0.85
-$0.99 – -$0.66
|
140 M | 6 |
Key Takeaways
Revenue grew 65.31% annually over 5 years — strong growth
Debt/Equity of 0.07 — conservative balance sheet
Negative free cash flow of -378.28M
PEG of 0.19 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 38.39%
Capital efficient — spends only 8.66% of revenue on capex
Growth
Revenue Growth (5Y)
65.31%
Revenue (1Y)26.92%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-59.54%
ROIC-40.21%
Net Margin-863.35%
Op. Margin-867.87%
Safety
Debt / Equity
0.07
Current Ratio5.50
Interest Coverage-358.08
Valuation
P/E Ratio
-2.20
P/B Ratio1.25
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 26.92% | Revenue Growth (3Y) | 30.46% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 65.31% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 74.68M | Net Income (TTM) | -644.76M |
| ROE | -59.54% | ROA | -43.74% |
| Gross Margin | -61.96% | Operating Margin | -867.87% |
| Net Margin | -863.35% | Free Cash Flow (TTM) | -378.28M |
| ROIC | -40.21% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.07 | Current Ratio | 5.50 |
| Interest Coverage | -358.08 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -2.20 | P/B Ratio | 1.25 |
| P/S Ratio | 18.98 | PEG Ratio | 0.19 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.42B | Enterprise Value | 752.27M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 74.68M | 58.84M | 43.88M | 39.68M | 10.00M |
| Net Income | -644.76M | -463.66M | -328.07M | -239.48M | -186.48M |
| EPS (Diluted) | -1.44 | -1.69 | -1.58 | -1.36 | -1.05 |
| Gross Profit | -46.27M | 13.60M | 1.29M | -8.59M | 10.00M |
| Operating Income | -648.13M | -479.00M | -350.06M | -245.73M | -182.78M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.47B | 1.45B | 653.70M | 701.29M | 610.35M |
| Total Liabilities | 343.27M | 413.82M | 190.26M | 215.48M | 67.41M |
| Shareholders' Equity | 1.13B | 1.03B | 463.44M | 485.81M | 542.94M |
| Total Debt | 77.97M | 108.49M | 50.67M | 51.01M | 11.48M |
| Cash & Equivalents | 743.29M | 594.35M | 391.57M | 549.91M | 285.12M |
| Current Assets | 812.85M | 714.27M | 438.14M | 569.81M | 534.72M |
| Current Liabilities | 147.71M | 187.47M | 93.17M | 100.27M | 46.66M |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Full Throttle
#101 of 146
Recent Activity
Entered
Full Throttle
Mar 24, 2026